Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Polypodium leucotomos with topical ingenol mebutate or topical colchicine for actinic keratosis
RBR-5q5dg8Not yet recruiting
- Sponsor
- UNESP Botucatu Medical School
- Start
- Apr 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Polypodium leucotomos, ingenol mebutate and colchicine in actinic keratosis (AK) and field cancerization (FC) (2 arms), sponsored by UNESP Botucatu Medical School. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
Polypodium leucotomosingenol mebutatecolchicine
03
Conditions
actinic keratosis (AK)field cancerization (FC)
Beyond the preview
Go deeper on RBR-5q5dg8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5q5dg8.